About Neuland

History of Neuland

26 Years of Neuland History


  • January 7, Neuland Laboratories was incorporated in Hyderabad.
  • June 30, Neuland made its first sale of salbutamol sulphate/albuterol sulfate.
  • Neuland went public with an IPO; raised capital for construction of second production facility.
  • Received first US FDA approval.
  • Both manufacturing facilities inspected by USFDA. Receieved Certificate of Suitability for Ranitidine.
  • US and EU markets contribute over 40% of Neuland’s sales.
  • Established North American operations.
  • Number of products with Certificate of Suitability reaches 9;
    US office started operations from California

  • Established Japanese subsidiary in Tokyo
    Inspected by German Health Authority (Unit – 2)

  • Certified in ISMS. SAP enabled Business Processes.
    Unit-1 successfully inspected by USFDA
    Unit-1 Certified for ISO 14001 and OHSAS 18001

  • Unit 1 & 2 receive approval from PMDA of Japan.
    Neuland is one of the first Indian API manufacturers to receive such an approval

  • Unit-2, Pashamylaram facility is certified for ISO 14001:2004 and OHSAS 18001:2007 standard.


Feedback